Grown Rogue International (GRUSF) Exchange Rate Effect (2009 - 2025)
Grown Rogue International (GRUSF) posted quarterly Exchange Rate Effect of -$4.0 billion for Q4 2025, down 59415294.82% year-over-year from N/an in Q4 2024, and down 85162903.57% quarter-over-quarter from -$4725.1 in Q2 2025.
Grown Rogue International (GRUSF) Exchange Rate Effect (2009 - 2025) Analysis & Trends
Grown Rogue International's Exchange Rate Effect history runs 13 years deep, the most recent figure standing at -$4.0 billion for Q4 2025.
- In Q4 2025, Exchange Rate Effect fell 59415294.82% year-over-year to -$4.0 billion; the TTM figure through Dec 2025 stood at -$4.0 billion (down 31084545.75% YoY), while the FY2025 annual figure was $4024.0, up 131.47% from the prior year.
- Exchange Rate Effect for Q4 2025 stood at -$4.0 billion, down from -$4725.1 in the prior quarter.
- The five-year high for Exchange Rate Effect was $2.8 billion in Q4 2021, with the low at -$4.0 billion in Q4 2025.
- The 5-year median for Exchange Rate Effect is -$607.53 (2021), against an average of -$28.6 million.
- The sharpest annual moves came in 2021 and 2025: Exchange Rate Effect surged 11719965.73% in 2021, then plunged 59415294.82% in 2025.
- Grown Rogue International's Exchange Rate Effect stood at $2.8 billion in 2021, then tumbled by 100.0% to $1427.7 in 2022, then tumbled by 262.36% to -$2317.9 in 2023, then sank by 192.18% to -$6772.6 in 2024, then tumbled by 59415294.82% to -$4.0 billion in 2025.
- Business Quant data shows GRUSF's Exchange Rate Effect at -$4.0 billion in Q4 2025, -$4725.1 in Q2 2025, and $5460.3 in Q1 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Exchange Rate Effect (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.83 Bn | 42.86 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 42.87 Bn | 39.22 Bn | 2.15 Bn | -5.00 Mn |
| 3 | Zoetis | 31.41 Bn | 29.73 Bn | 1.05 Bn | -7.00 Mn |
| 4 | Takeda Pharmaceutical | 28.55 Bn | 22.75 Bn | 5.10 Bn | 39.87 Mn |
| 5 | United Therapeutics | 22.08 Bn | 19.42 Bn | 683.80 Mn | - |
| 6 | Viatris | 18.73 Bn | 17.84 Bn | 1.46 Bn | -3.30 Mn |
| 7 | Neurocrine Biosciences | 15.44 Bn | 15.05 Bn | 935.80 Mn | - |
| 8 | Elanco Animal Health | 11.75 Bn | 11.22 Bn | 798.00 Mn | 9.00 Mn |
| 9 | Dr Reddys Laboratories | 10.11 Bn | 9.94 Bn | - | - |
| 10 | Grown Rogue International | 109.32 Mn | 97.78 Mn | 5.37 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -4.02 Bn |
| Dec 31, 2025 | -4.02 Bn |
| Jun 30, 2025 | -4,725.05 |
| Jun 30, 2025 | -4,725.05 |
| Mar 31, 2025 | 5,460.34 |
| Mar 31, 2025 | 5,460.34 |
| Dec 31, 2024 | -6,772.65 |
| Dec 31, 2024 | -6,772.65 |
| Sep 30, 2024 | -387.05 |
| Sep 30, 2024 | -387.05 |
| Jun 30, 2024 | -3,752.21 |
| Jun 30, 2024 | -3,752.21 |
| Mar 31, 2024 | -2,033.39 |
| Mar 31, 2024 | -2,033.39 |
| Oct 31, 2023 | -2,317.94 |
| Oct 31, 2023 | -2,317.94 |
| Jan 31, 2023 | 691.72 |
| Jan 31, 2023 | 691.72 |
| Jan 31, 2022 | 1,427.68 |
| Jan 31, 2022 | 1,427.68 |